Long-term therapeutic response to dupilumab in patients affected by prurigo nodularis: A real-world retrospective study

J Eur Acad Dermatol Venereol. 2024 Oct;38(10):e892-e895. doi: 10.1111/jdv.19980. Epub 2024 Mar 27.

Authors

Andrea Chiricozzi^{1

2}, Niccolò Gori^{1

2}, Elena Ippoliti^{1

2}, Martina Maurelli³, Flaminia Antonelli^{1

2}, Giulia Coscarella^{1

2}, Elisabetta Rizzo², Lucia Di Nardo^{1

2}, Giampiero Girolomoni³, Ketty Peris^{1

2}

Affiliations

¹ Dermatologia, Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
² Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
³ Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.

PMID: 38534078
DOI: 10.1111/jdv.19980

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Antibodies, Monoclonal, Humanized* / therapeutic use
Female
Humans
Male
Middle Aged
Prurigo* / drug therapy
Retrospective Studies
Treatment Outcome

Substances

dupilumab
Antibodies, Monoclonal, Humanized